[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "April Canada Update", "description": "References for today's discussion: (the one where John messed up his camera work)\n\nFriendly Pharmacy 5: https://www.youtube.com/c/FriendlyPharmacy5\n\nCOVID-19 Resources Canada: www.covid19resources.ca\n\nPost-Vaccine Transmission Data, Mammograms & Vaccines, Variants, Outdoor Risk, Therapeutics: https://www.youtube.com/watch?v=aVnuDMCRkOE\n\nDr. Marcia Castro, Harvard: P1 Variant in Brazil, Herd Immunity, Vaccination, Global Concerns: https://www.youtube.com/watch?v=aRasUNXfy5U&t=2199s\n\nCanada Update: Vaccine Safety Report, AstraZeneca, Variants, RISK: https://www.youtube.com/watch?v=5HpkCzZY2HI&t=389s\n\nHealth Canada Epidemiological Summary: https://health-infobase.canada.ca/src/data/covidLive/Epidemiological-summary-of-COVID-19-cases-in-Canada-Canada.ca.pdf\n\nCOVID-infected people arrive in B.C. from India as Trudeau ponders flight restriction: https://vancouversun.com/news/local-news/covid-sick-people-arrive-in-b-c-from-india-as-trudeau-ponders-restriction\n\nPPE must guard against airborne transmission of COVID-19, nurses' union demands: https://www.cbc.ca/news/canada/ottawa/ottawa-ontario-nurses-union-court-case-1.5989081\n\nHealth Canada Vaccine Adverse Effects Report: https://health-infobase.canada.ca/covid-19/vaccine-safety/", "link": "https://www.youtube.com/watch?v=nKM7YpAf8CE", "date_published": "2021-04-22 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Unnecessary deaths in India", "description": "England, 95% of over 50s have had first dose\n\nhttps://www.bbc.co.uk/news/health-56849874\n\n45-49 at 59% so far\n\nCare home staff, 80%\n\nProportion of over 18s vaccinated in UK\n\nhttps://coronavirus.data.gov.uk\n\nPatients in hospital\n\n2% of hospital beds\n\n Zoe latest\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nNE highest\n\nSW lowest\n\nNo big surges in South London (SA variant)\n\nNo data on India variant yet\n\nChance of contracting CoViD in next 24 hours\n\nNo vaccine 1 in 46,000\n\n12 days after first dose 1 in 74,000\n\n12 days after 2nd dose 1 in 114,000\n\nLancet paper next week\n\nPeople in care homes with two vaccines should be given more freedoms\n\nE mail from CDC to CNN, Breakthrough infections\n\nhttps://www.medscape.com/viewarticle/949381?src=wnl_edit_tpal&uac=127834AR&impID=3316056&faf=1\n\nhttps://edition.cnn.com/2021/04/14/health/breakthrough-infections-covid-vaccines-cdc/index.html\n\nVaccinated people who become infected, 1 in 13,275\n\nOf these, asymptomatic 29%\n\nRequired hospitalization 1 in 194,444\n\nDeaths 1 in 1,040,540\n\nUS\n\nVaccine tipping point?\n\nPoint where supply outstrips demand\n\nThis week, 3 million per day\n\nLast week, 3.3 million per day\n\nSummertime, hopes life will return to normal\n\nIndia\n\nhttps://www.bbc.co.uk/news/world-asia-india-56826645\n\nHighest ever one day total anywhere\n\nCases, + 314,835 = 16 million\n\n(US, 8th Jan, + 313,000)\n\n30% positivity rates\n\nDeaths, 2,104 = 185,000\n\nCrowds outside hospitals\n\nPeople dying waiting for admission\n\nOxygen supply variable\n\nDeputy Delhi Chief Minister, Manish Sisodia\n\nSome hospitals have run out of oxygen\n\nDelhi crematorium resorting to building pyres in its car park \n\nSpecific example\n\nNashik, Western India\n\nhttps://www.washingtonpost.com/world/2021/04/21/india-hospital-oxygen-deaths/\n\nBroken valve on oxygen tank\n\n150 CoViD patients\n\n22 died\n\nPrime Minister Narendra Modi\n\nAsked officials to find ways to produce more oxygen\n\nStates to come down heavily on anyone hoarding supplies\n\nCurfew in Delhi, increased restrictions in Maharashtra \n\nVaccines, 130 million so far\n\nEvidence going back more than 30 years suggests that platelets can biosynthesize proteins\n\nhttps://www.tandfonline.com/doi/abs/10.1080/09537100801990582?journalCode=iplt20\n\nSweden\n\nhttps://www.dw.com/en/do-swedens-covid-liberties-cost-lives/a-57268022\n\nSize limitations on public gatherings\n\n8 p.m. closing time for restaurants and pubs\n\nOther, recommendations\n\nJanuary, passengers on public transportation encouraged to face cover\n\nSouth Africa\n\n31 million doses of the J&J\n\n30 million doses of Pfizer BioNTech\n\nhttps://www.washingtonpost.com/nation/2021/04/22/coronavirus-covid-live-updates-us/\n\nResume using the Johnson & Johnson vaccine\n\nSouth Africa, no reports of unusual blood clots\n\n290,000 of 1.2 million health workers have been given the J&J vaccine in a study", "link": "https://www.youtube.com/watch?v=6nQbVIsvsJU", "date_published": "2021-04-22 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Infections increasing globally", "description": "Global increases in cases\nhttps://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---20-april-2021\n\nCases, increased for past 8 weeks\n\nCases, + 5.2 million (7 days)\n\nDeaths increased for past 5 weeks\n\nDeaths, + 83,000 (7 days) up 7% on last week\n\nSouth-East Asia, India, Western Pacific Region\n\nUnited Arab Emirates\n\nPopulation 9.8 million\n\nSinopharm and Pfizer\n\nAt least one dose, 65%\n\nTwo doses, 38%\n\nConsidering restricting movements of unvaccinated\n\nNational Emergency Crisis and Disasters Management\n\nDelaying or refraining from taking the vaccine will pose a threat to the safety of society \u2026 as it poses a major challenge to the national efforts to recover\n\nstrict measures are being considered\n\nrestrict the movement of unvaccinated individuals\n\nimplement preventive measures such as restricting entry to some places and having access to some services\n\nIsrael\n\nSome indoor venues, theatres and restaurants\n\nItaly\n\nNational government decree, that if a health care worker, hospitals, nursing homes, or other facilities where they are in contact with patients\n\nThen they have to accept a different work position with no contact with patients, or they will be dismissed.\n\nIntroducing Green Pass while waiting for the official EU health passport\n\nIndian airline flight, Delhi to Hong Kong, 4th April\n\nhttps://nypost.com/2021/04/20/dozens-of-passengers-test-positive-for-covid-on-flight-from-india/\n\nUp to 188 passengers\n\nAll tested negative within 72 hours of boarding\n\n53 tested positive\n\nEmerged during mandatory three-week quarantine\n\nAlso several cases from Mumbai flights\n\nIntroduced an emergency 2 week ban on flights from India, Pakistan and the Philippines\n\nBrazil\n\nJohnson & Johnson coronavirus vaccine, EMA, 20th April\n\nConfirms positive risk benefit analysis\n\nhttps://www.jnj.com/johnson-johnson-covid-19-vaccine-roll-out-to-resume-in-europe-following-european-medicines-agency-ema-reviewema-confirms-overall-benefit-risk-profile-remains-positive\n\nhttps://www.washingtonpost.com/nation/2021/04/21/coronavirus-covid-live-updates-us/\n\nhttps://edition.cnn.com/2021/04/20/europe/ema-johnson-johnson-vaccine-blood-clot-ruling-intl/index.html\n\nhttps://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen\n\nConcluded that a warning about unusual blood clots with low blood platelets should be added to the product information\n\nShould be listed as very rare side effect of the vaccine\n\nBased on 7 million vaccinations in the US, 8 cases\n\nAll cases occurred in people under 60\n\nWithin three weeks after vaccination\n\nThe majority in women\n\nSpecific risk factors have not been confirmed\n\nPlausible explanation, an immune response, similar to heparin induced thrombocytopenia, HIT\n\nReport for senior review\n\nShortness of breath\n\nChest pain\n\nLeg swelling\n\nPersistent abdominal (belly) pain\n\nNeurological symptoms, such as severe and persistent headaches or blurred vision\n\nTiny blood spots under the skin beyond the site of the injection", "link": "https://www.youtube.com/watch?v=7_-8uTslpfQ", "date_published": "2021-04-21 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]